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Animals require an immediate response to oxygen
availability to allow rapid shifts between oxidative
and glycolytic metabolism. These metabolic shifts
are highly regulated by the HIF transcription factor.
The factor inhibiting HIF (FIH) is an asparaginyl
hydroxylase that controls HIF transcriptional activity
in an oxygen-dependent manner. We show here
that FIH loss increases oxidative metabolism, while
also increasing glycolytic capacity, and that this
gives rise to an increase in oxygen consumption.
We further show that the loss of FIH acts to accel-
erate the cellular metabolic response to hypoxia.
Skeletal muscle expresses 50-fold higher levels of
FIH than other tissues: we analyzed skeletal muscle
FIH mutants and found a decreased metabolic
efficiency, correlated with an increased oxidative
rate and an increased rate of hypoxic response.
We find that FIH, through its regulation of oxidation,
acts in concert with the PHD/vHL pathway to
accelerate HIF-mediated metabolic responses to
hypoxia.
INTRODUCTION
In eukaryotes, oxygen is the terminal electron acceptor in respi-
ration and is essential for the synthesis of both cellular machin-
ery and signaling molecules. Hypoxia-inducible factors (HIFs)
are key regulators of the transcriptional response to shifts in
oxygenation (Semenza and Wang, 1992). Many metabolic pa-
thologies arise from inappropriate changes in HIF activity (Gir-
gis et al., 2012), underscoring the need for regulation of HIF
function.
The activity of the heterodimeric HIF transcription factor com-
plex depends on both the abundance (Wang and Semenza,898 Cell Metabolism 27, 898–913, April 3, 2018 ª 2018 The Author(s)
This is an open access article under the CC BY license (http://creative1993) and the transactivational capacity of the alpha subunits
(HIF-a) (Mahon et al., 2001). Their abundance is regulated by
prolyl hydroxylases (PHDs) 1–3, which hydroxylate proline resi-
dues on HIF-a (Epstein et al., 2001), enabling the von Hippel-
Lindau (vHL) ubiquitin ligase complex to target HIF-a (Jaakkola
et al., 2001) for proteasomal degradation (Maxwell et al., 1999).
Oxygen is absolutely required for hydroxylase activity. As oxy-
gen levels drop, HIF-a escapes vHL-mediated degradation and
accumulates (Min et al., 2002).
HIF-a transactivational capacity is controlled by an aspara-
ginyl hydroxylase (factor inhibiting HIF, or FIH) (HIF-1AN), acting
on Asn803 in the C-terminal domain (C-TAD) of the HIF-1a pro-
tein. The hydroxylation of this residue prevents HIF from recruit-
ing the transcriptional coactivator and histone acetyltransferase
p300/CBP to the HIF-a C-TAD (Dames et al., 2002; Lando et al.,
2002). Repression of FIH activity under hypoxia is both neces-
sary and sufficient for disinhibition of HIF-1a C-TAD activity
(Lando et al., 2002;McNeill et al., 2002; Zhang et al., 2010).While
there are three major PHD isoforms, there is only one known FIH
isoform (Elkins et al., 2003; Mahon et al., 2001), and in its
absence, no hydroxylation of the Asn803 residue occurs (Zhang
et al., 2010).
FIH and the PHDs share some enzymatic properties, including
cofactors and by-products (Hewitson et al., 2002); this has led to
the assumption that PHDs and FIH are functionally redundant in
their regulation of HIF. It has also been difficult to account for
FIH’s distinct evolutionary history as an oxygen sensor (Hamp-
ton-Smith and Peet, 2009; Taylor and McElwain, 2010): FIH
was present in the very earliest stages of the evolution of animal
oxygen sensing, but is absent in a few intermediate forms,
including some arthropods, while preserved in most others,
including all vertebrates.
An interesting dilemma in understanding the role of FIH
contra the PHD/vHL pathway is that FIH has a lower Km for ox-
ygen than the PHD enzymes (Ehrismann et al., 2007; Tarhon-
skaya et al., 2015). An additional complexity is the data that
indicate that the HIF-1a isoform is more susceptible to FIH
modification than the other major HIF isoform, HIF-2a (Bracken
et al., 2006; Koivunen et al., 2004). HIF-1a is the HIF-a isoform. Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
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that directly regulates expression of many of the enzymes that
control metabolism (Keith et al., 2012); thus, a differential con-
trol of HIF-1a by FIH could potentially trigger specific shifts in
metabolic response. However, the fact that FIH is still an active
hydroxylase at lower oxygen levels than those that would
trigger HIF accumulation indicates that FIH could be particu-
larly relevant where a rapid onset of hypoxia outstrips the
process of HIF-1a accumulation (by PHD inhibition). In other
words, the FIH pathway could serve as a failsafe for when
an inappropriate, relative deficiency of HIF places the cell at
a metabolic disadvantage.
We have shown that FIH nullizygous mice have an increased
lean muscle mass and an increased mass-specific VO2 (Zhang
et al., 2010). This was surprising, as other data showed that
HIF-a overexpression via loss of vHL or PHD1 results in
decreased oxygen consumption in cells (Aragones et al., 2008;
Fukuda et al., 2007; Kim et al., 2006; Papandreou et al., 2006;
Zhang et al., 2008) and animals (Yaqoob and Schwerte, 2010).
Animals with HIF overexpression via the PHD/vHL pathway
also show impaired aerobic exercise capacity (Aragones et al.,
2008; Formenti et al., 2010; McClain et al., 2013), despite
increased muscle capillarization (Karsikas et al., 2016; Lijkwan
et al., 2014).
The roles of FIH in cellular metabolism have thus to date been
unclear. Hypoxic cells express a preference for anaerobic meta-
bolism, which can lead to a catabolic state (Frezza et al., 2011)
depending on the cell’s nutrient status. Indeed, pan-PHD dele-
tion (Duan et al., 2014), and singular PHD1 (Aragones et al.,
2008), PHD2 (Minamishima et al., 2009), or vHL loss (Hervouet
et al., 2005; Wise et al., 2011; Zhang et al., 2007) all give rise to
the classical cellular response to hypoxia, i.e., decreased mito-
chondrial activity, increased glycolysis, and glycogen and lipid
accumulation.
In this study, we demonstrate that FIH has a specific role in the
control of metabolism, a role essential for potentiation of meta-
bolic responses to shifts in oxygenation. This role diverges
from the role of the PHD/vHL pathway, acting to accelerate the
rate of oxygen consumption, and we propose that this can
increase the rapidity and magnitude of the hypoxic response.Figure 1. FIH Is a Non-redundant Regulator of Metabolic Parameters a
(A) Heatmap analysis of microarray data: each row denotes a sample, while eac
normalized to column means. Red indicates that a transcript has been significant
total of 5,000 genes that varied the most with genotype are depicted here.
(B) Scatterplot analysis of microarray data: fold change in gene expression that res
mRNA transcript. Fold change expression following FIH loss (x axis), and fold ch
concomitantly knocking out vHL and FIH together compared with single FIH loss
with metabolic Kyoto Encyclopedia of Genes and Genomes annotations are high
(C) qRT-PCR analysis of control MEFs and KOMEFs. Dark red shading indicates
shading indicates a downregulation. A two-way ANOVA analysis was performed
significant interaction between time exposed to hypoxia and genotype (p < 0.00
effect on gene expression (p < 0.0001). The leftmost column in each section reflect
to the effect of genotype and indicated duration of hypoxic exposure.
(D) Heatmap analysis of 1H-nuclear magnetic resonance (NMR) data. Red indicate
while green indicates downregulation. Each column denotes an independent cell c
are shown.
(E) Heatmap of 1H-NMR data performed in MetaboAnalyst: aqueous metabolites
(F) Principal component analysis (PCA) of 1H-NMR data performed in MetaboAna
genotype is demarcated by a 95% confidence interval (oval).
(G) PCA of 1H-NMR data performed in MetaboAnalyst: each data point denotes
See also Figure S1.
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Quantitative Effects of FIH Loss on the Metabolic
Transcriptome
Microarray analysis of an FIH/vHL null cell dataset (GEO:
GSE20335) (Figure 1A) from mRNA derived from murine embry-
onic fibroblasts (MEFs) (Figure S1A) under normoxic culture
shows that FIH loss affects the transcriptome differently than
vHL loss. In an analysis of individual gene changes, FIH is able
to act both as an inducer and a suppressor of a variety of genes,
including genes that have Kyoto Encyclopedia of Genes and Ge-
nomes annotations in metabolic pathways (Figure 1B), and there
is a clear differentiation between the effects of FIH deletion and
vHL deletion across the metabolic transcriptome. Deletion of
both factors, as in the broader transcriptome, has differentiable
effects from either single deletion.
In Figure 1B, there appears to be no relation between fold
change in gene expression in vHL null cells and fold change in
FIH null cells (left panel), but a reasonable correlation between
the effect of FIH inactivation in vHL null cells and that of vHL inac-
tivation in FIH null cells (right panel). One explanation would be
that FIH and vHL have concordant effects in the presence of
large amounts of HIF protein, but that FIH has additional or
different actions when HIF levels are low. It has been noted
that the N termini of FIH and vHL interact with HIF-1a at distinct
sites (Mahon et al., 2001) to recruit different HDACs. When
HIF-1a is abundant, it could scaffold the interaction of FIH and
vHL, such that the inactivation of either influences the other.
Metabolic Differences in FIH and vHL Null Cells
To determine how hypoxia affects FIH regulation of metabolic
genes, a qRT-PCR study of selected transcripts in MEFs was
carried out. We found that FIH acting alone in cells at 21% oxy-
gen levels again differentiates these two post-translational regu-
lators of HIF expression (Figure 1C). At 0 hr (normoxia), vHL loss
increases expression of most glycolytic genes, while causing
decreased levels of a range of genes controlling oxidative meta-
bolism. These changes in expression continue into the early time
points of hypoxic (1% oxygen) conditioning. FIH loss increasesnd Metabolic Gene Expression
h column denotes a gene transcript; net fold changes in gene expression are
ly upregulated relative to the column mean; green indicates downregulation. A
ults from acute FIH versus vHL deletion inMEFs. Each data point represents an
ange expression following vHL loss (y axis) for the first plot, and the effect of
(x axis), and compared with single vHL loss (y axis) for the second plot. Genes
lighted in red.
an upregulation of the gene transcript relative to control MEFs at 0 hr; light blue
, to dissect the contributions of genotype and time to expression. ^ Denotes a
01) on gene expression, while * denotes that genotype alone has a significant
s genotypic comparisons between normoxic cells, whereas the other data refer
s that a metabolite has been significantly upregulated relative to the rowmean,
ulture sample. Only aqueousmetabolites with the highest absolute abundance
in whole MEF lysates.
lyst: each data point denotes an independent cell culture media sample. Each
an independent sample of whole-cell lysates.
glycolytic gene expression over 8–72 hr of hypoxia, but clamps
oxidative gene expression in normoxia and early hypoxia, rather
than suppressing it. Note specifically that there are significant
differences in FIH and vHL regulation of cox4i1/2 and cox7i1/2
transcripts; their expression is known to be sensitive to prevail-
ing oxygen levels (Fukuda et al., 2007; Hwang et al., 2015). Sub-
unit 4, in particular, is rate-limiting for complex IV assembly and
function, with implications for cell survival and ATP levels in hyp-
oxia (Li et al., 2006).
To determine how these gene expression changes act on
cellular metabolism, a 1H-nuclear magnetic resonance metabo-
lomics analysis was performed on extracellular metabolites from
media samples following 48 hr of cell culture (Figure 1D; Tables
S2 and S3), and on cell lysates (Figure 1E). There is a clear
separation of FIH null, vHL null, and control aqueous metabolite
profiles, with lactate, alanine, glucose, and glutamine showing
significant fold changes (Figure 1F). Intracellular aqueous me-
tabolites of FIH null and control cells weremorewidely separated
(Figure 1G) than between vHL null and control cells, indicating
significant and distinct metabolic differences in cells with and
without FIH.
FIH Modulates a Hypoxic Metabolic Shift
vHL and vHL/FIH double null MEFs show increases in lactate
production and glucose uptake relative to wild-type (WT) cells,
but FIH null cells do not (Figures S2A and S2B). However, loss
of FIH increases both lactate production and glucose uptake
by these cells during prolonged exposure to 1% oxygen over
72 hr (Figures 2A and 2B). This indicates that FIH has a role in
modulating hypoxic response even at levels of oxygen as low
as 1%, in keeping with the high oxygen affinity of the FIH
enzyme. Elevated ATP levels seen in FIH null cells in normoxia
(Figure 2C) are lost after 48 hr of exposure to hypoxia.
In sum, the loss of FIH increases both lactate production and
glucose uptake over prolonged exposure to 1% O2, but not un-
der 21% O2. Nevertheless, in Figure 2C, FIH knockout (KO)
MEFs have elevated ATP levels at normoxia. We speculate that
this is the result of certain oxygen-dependent, anaplerotic path-
ways becoming hyperactive when FIH is lost, thus permissive for
high ATP levels in the cell (albeit with a normal ATP:AMP ratio,
i.e., energy supply/demand is balanced). When oxygen is
limiting, these pathways are thrust into glucose dependence,
or redirected into lactate-producing pathways.
Interestingly, vHL null cells also show an elevated level of ATP
relative to WT MEFs; this is not seen in FIH/vHL null cells (Fig-
ure 2D). The overall ratio of ATP:AMP is greatly reduced in vHL
null cells, but is not reduced significantly in either FIH null or
FIH/vHL null cells (Figure 2E), indicating that, coupled to the
higher levels of ATP in vHL null cells, there is also a greater
rate of ATP turnover. This indicates that there are likely higher
cellular energetic demands in vHL null MEFs, and that these
are reduced when FIH is also deleted. These data, taken
together, argue for an energetically complementary function of
these two negative regulators, a synergy that is acting to balance
metabolic function during hypoxic response. Further evidence
for this comes from cell survival rates: under normoxia, vHL
null MEFs have an increased rate of apoptosis, and FIH/vHL
null MEFs have an even higher rate of cell death (Figure 2F),
whereas the opposite is the case in hypoxia, where FIH nullMEFs have a higher rate of apoptosis, and FIH/vHL null MEFs
have a significant survival advantage (Figure 2G).
FIH Suppresses Hypoxia-Induced Mitochondrial
Reactive Oxygen Species Production
Key aspects of hypoxic adaptation include a shift of cytochrome
oxidase subunits (Aras et al., 2013; Fukuda et al., 2007) and the
induction of superoxide dismutase (Rasbach et al., 2010; Scor-
tegagna et al., 2003), both limiting the production of reactive ox-
ygen species (ROS). Loss of FIH does not affect mitochondrial
superoxide production at normoxia, but loss of vHL results in a
reduction of superoxide production, as measured by the Mito-
SOX assay (Figures 2H and S2C). Interestingly, further loss of
FIH eliminates this difference in ROS production seen in vHL
null MEFs, arguing that there is a compensating shift in ROS
handling caused by the double deletion. Prolonged culture in
hypoxia causes a marked increase in ROS production in WT
MEFs (Figures 2I and S2D). However, this increase in ROS under
hypoxia is significantly suppressed by the loss of FIH, again indi-
cating that FIH is regulatingmitochondrial activity, and indicating
as well that native FIH activity has not been completely sup-
pressed at 1% oxygen, even after 2 days of hypoxic culture.
Shift in Mitochondrial Membrane Potentials Is Induced
by vHL Loss, but Not FIH Loss
The increases in apoptosis in FIH null MEFs in hypoxia, and in
vHL and FIH/vHL null MEFs in normoxia, as well as changes
induced in mitochondrial ROS production, indicate that FIH
may play a role in regulating mitochondrial energetics that is
separable from the role played by vHL. As seen in Figures 3A
and S2E, loss of vHL significantly decreases mitochondrial
membrane potential in normoxia; loss of both FIH and vHL phe-
nocopies loss of vHL alone. This indicates that the PHD/vHL axis
has primary control over mitochondrial potential, unlike FIH,
which has little effect on mitochondrial potential in either nor-
moxia or hypoxia (Figures 3B and S2F). Thus, FIH modulates
ROS production without an effect on mitochondrial potential.
Mitochondrial Levels and Activity Differ in FIH and vHL
Null MEFs
There is a significant reduction in mtDNA in both vHL and FIH/
vHL null MEFs, with an almost 50% reduction in vHL null cells
(Figure 3C). This correlates with an overall reduction in citrate
synthase activity per cell in the vHL null cells (Figure 3D), with
no corresponding change in FIH null MEFs. In addition, culture
of FIH null MEFs in hypoxia accelerates the loss of mitochondrial
citrate synthase relative to the decline seen in WT cells (Fig-
ure 3E). This demonstrates that FIH loss accelerates the effects
of hypoxic exposure on mitochondria.
Loss of FIH Increases Mitochondrial Activity under
Normoxia
The data above demonstrate the role of FIH in preserving meta-
bolic hypoxic response when some oxygen is still available, e.g.,
at 1% oxygen, and indicates that complete loss of FIH function
accelerates a shift both to a glycolytic metabolism and to a
reduced level of mitochondrial functioning.
There is a tripling of cytochrome c oxidase (COX) activity in
FIH KOs relative to WT cells (Figure 3F). Normalized to citrateCell Metabolism 27, 898–913, April 3, 2018 901
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Figure 2. FIH Loss Promotes Glycolysis in Hypoxia, but Not Normoxia
(A) Enzyme-based colorimetric assay of culture media lactate.
(B) Enzyme-based colorimetric assay of culture media glucose.
(C) HPLC-based ATP measurements from cell lysates.
(D) HPLC-based ATP measurements from cell lysates.
(E) AMP:ATP ratio in cell lysates.
(F) 70-AAD flow cytometric apoptosis assay for cells cultured in atmospheric oxygen.
(G) 70-AAD flow cytometric apoptosis assay for cells cultured in 1% oxygen for 3 days.
(H) Flow cytometry; histogram of cell count versus MitoSOX (superoxide stain) fluorescence, with shaded graph representing unstained controls. Three
experiments were performed with two biological replicates each; the histogram provided is representative of one of these experiments.
(I) Flow cytometry; histogram of cell count versus MitoSOX fluorescence, with shaded graph representing unstained controls.
*p < 0.05, **p < 0.01. Data are represented as means ± SEM. For grouped data (A–C), a two-way ANOVA was used. For multiple comparisons (D–G), a one-way
ANOVA was used. For pairwise comparisons (H and I), a two-tailed Student’s t test was used. n = 3 independent cell culture samples per genotype, unless
otherwise specified. See also Figure S2.
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synthase activity, and thus to mitochondrial density, we see an
almost 4-fold increase in COX activity as a function of mitochon-
drial content (Figure 3G), which is reduced over 48 hr of exposure
to hypoxia (Figure 3H), and lessened as a function of mitochon-
drial density (Figure 3I). This indicates that the loss of FIH function
drives an increase in oxidative metabolism, although this is sub-
sequently lost as hypoxia drives additional adaptations. The loss
of FIH drives an increase in electron transport chain components
complex II and IV at baseline (Figure 3J), despite the preservation
of mitochondrial content shown earlier. Interestingly, in parallel
with the loss of mitochondrial activity with hypoxia, the differ-
ences in complex II/IV expression between WT and KO cells
diminish with prolonged exposure to hypoxia (Figure 3K).
Loss of FIH under Normoxia Selectively Increases
Glycolytic Reserve
To better map metabolic cellular responses of the two HIF post-
translational modification mutants, we analyzed proton genera-
tion and oxygen consumption in KO MEFs. Loss of FIH does
not change acidification rates relative toWT cells, demonstrating
that glycolytic rates in these cells are normal; however, the
glycolytic reserve is increased significantly (Figure 4A). This indi-
cates that loss of FIH can in some regard metabolically prepare
cells for hypoxic glycolytic metabolism. Further evidence of this
is seen in Figure 4B, where hypoxic FIH null cells have increased
glycolytic rates in addition to a preserved increase in glycolytic
reserve. This is compared with the changes in vHL null cells (Fig-
ure 4C), which demonstrate increases in both glycolytic reserves
and rates typically seen when the PHD/vHL axis is suppressed,
or when HIF-1a is overexpressed. Interestingly, although the
FIH/vHL KO cells are more glycolytic relative to WT cells (Fig-
ure 4D), there is no further increase seen when oligomycin is
added to inhibit the mitochondrial ATP synthase. Where both
FIH and vHL are fully suppressed, glycolytic activity is equivalent
to glycolytic capacity, i.e., the cells are maximally glycolytic,
deriving energy mostly from glycolysis as opposed to oxidation.
Loss of FIH under Normoxia Increases Oxygen
Consumption
The loss of FIH causes an overall increase in cellular basal respi-
ration (Figure 4E), and this effect is reversedwhen the FIH gene isFigure 3. Differential Regulation of HIF Leads to Differential Regulatio
(A) Flow cytometry; histogram of cell count versus TMRM fluorescence, with shad
with two biological replicates each; this series of histograms is representative of
(B) Flow cytometry; histogram of cell count versus TMRM fluorescence, with shad
with two biological replicates each; this pair of histograms is representative of on
(C) mtDNA abundance in indicated cells.
(D) Citrate synthase activity measured in indicated cells.
(E) Citrate synthase activity in FIH KO compared with control MEFs over prolong
(F) FIH, but not vHL KO cell lysates show higher mitochondrial cytochrome c oxi
(G) Cytochrome oxidase activity of FIH KO MEFs normalized to citrate synthase
(H) FIH KO MEFs have higher cytochrome oxidase activity than control cells in a
(I) The trends described in (H) persist even when the cytochrome oxidase activity
(J) Western blot of control versus FIH KO MEFs with lamin B as a loading contro
transport chain complex content in MEF lysates.
(K) Western blot of mitochondrial complex content in control versus FIH KO MEF
*p < 0.05, **p < 0.01, ***p < 0.001. Data are represented asmeans ± SEM. For pairw
comparisons (C, D, F, andG), a one-way ANOVAwas used. For grouped data (E, H
per genotype, unless otherwise specified.
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This unexpected result is in contrast to the expected change in
cellular oxygen consumption caused by the loss of vHL (Fig-
ure 4F). In vHL null cells, there is essentially an elimination of
the spare respiratory capacity. This is consistent with previous
studies of vHL null cells where mitochondrial mass is decreased
(Haase, 2012; Hervouet et al., 2005; Zhang et al., 2007), and
confers the functional advantage of suppressing respiration in
an oxygen-poor environment. vHL/FIH KO MEFs (Figure 4G)
differ from both single FIH and vHL KOs, with a lower basal respi-
ration rate, as well as a reduced spare respiratory capacity. The
loss of both of these negative regulators of HIF response has the
capacity to switch cells almost fully to a highly glycolytic state,
yet interestingly, double deletion also appears to allow a greater
sparing of respiratory capacity.
The effect of FIH loss on respiration is essentially eliminated
by culture at 1% oxygen for 72 hr (Figure 4H). This indicates
that the increased basal respiration and increased respiratory
capacity are suppressed by hypoxic response; interestingly,
the respiratory response seen in these cells is essentially iden-
tical to that seen in FIH/vHL null cells under normoxic condi-
tions in Figure 4G. This would argue that the chief modulators
of metabolic change in respiration under hypoxia are these
two negative regulators of the HIF pathway. As seen in Figures
4B and 4D, the glycolytic shift is more complex in this regard,
although another interpretation of this would be that a full
equivalence between glycolytic rate and glycolytic reserve
would require an even lower degree of hypoxia than 1% oxy-
gen conditions provide.
The increased oxygen consumption in FIH null MEFs is not due
to an increased capacity for fatty acid oxidation (Figure 4I), as
FIH null cells in fact have lower basal respiration and lower oxida-
tive reserve capacity than control cells when supplied solely with
palmitate as a substrate for oxidation. This experiment indicates
that FIH null cells are unable to fully switch to fatty acid oxidation.
In addition, when both glucose and palmitate are absent, FIH null
cells have the same spare respiratory capacity asWT cells, but a
lower basal oxygen consumption. This means that WT cells are
oxidizing a substrate in the basal state that FIH null cells cannot,
a substrate that cannot be used by the mutant cells to increase
spare respiratory capacity.n of Mitochondrial Parameters
ed graph representing unstained controls. Three experiments were performed
one of these experiments.
ed graph representing unstained controls. Three experiments were performed
e of these experiments.
ed exposure to hypoxia.
dase activity (p = 0.049) than control MEFs.
activity.
tmospheric oxygen, but this effect is blunted over hypoxic exposure.
of FIH KO and control MEFs is normalized to citrate synthase activity levels.
l and rat heart mitochondria as a positive control; demonstrates total electron
s, with progressive hypoxic exposure.
ise comparisons (A and B), a two-tailed Student’s t test was used. For multiple
, I, and K), a two-way ANOVAwas used. n = 3 independent cell culture samples
A B
C D
G
H I
E F
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These data indicate that FIH null cells have a block in fatty acid
oxidation and likely oxidation of other substrates. This, coupled
to the data in Figure 4A, argues that FIH null cells channel as
much glucose as possible through pyruvate to the mitochondria
due to this block, and thus have a lower rate of lactate production
as a result at baseline than, for example, vHL null cells. However,
when respiration is blocked by oligomycin, the increase in lactate
production reveals the higher rate of glycolysis in these cells.
Despite a low capacity for fatty acid oxidation, the finding
that FIH null cells maintain higher ATP levels with preserved
ATP:AMP ratios suggests that the alternate oxidative pathways
FIH null cells channel their large glycolytic reserve into, and
use to make up for their diminished fatty acid oxidation, are
energetically favorable.
Loss of FIH in Skeletal Muscle Demonstrates Its Role in
the Potentiation of Hypoxic Metabolic Shifts
Based on the data above, we postulated that tissues experi-
encing rapid and dynamic fluxes in oxygenation, and that need
to rapidly adjust their metabolic activity in response to those
fluxes, would be those most sensitive to the loss of FIH function.
Indeed, there is significant variation in FIH expression across tis-
sues of the mouse, with by far the highest levels of expression
found in skeletal muscle (Figure 5A). These elevated levels are
restricted to skeletal muscle, not being seen in intestinal smooth
muscle or cardiac muscle.
Interestingly, FIH expression is uniformly high in both fast and
slow twitch muscle, whereas among the PHD isoforms, PHD3
levels are highest in predominantly fast twitch muscles, and
PHD2 in the soleus, a predominantly oxidative, slow twitch mus-
cle (Figure 5B). These data support HIF-1a’s role in regulating
skeletal muscle metabolism (Mason et al., 2004, 2007). To deter-
mine the relationships between FIH and metabolic function
in vivo, we carried out studies of treadmill regulated running on
mice deficient in FIH/vHL.
To understand basal roles of FIH in exertion-induced meta-
bolic shifts, we first analyzed FIH global deletion animals. As
previously shown, these animals had a higher basal metabolic
rate (Zhang et al., 2010), seen here during the initiation of exer-
tion (Figure 5C). This elevated metabolic rate is also evident
over increasing speeds in an uphill treadmill protocol (Fig-
ure 5C). Global deletion of vHL is not compatible with post-Figure 4. FIH Specifically Determines Glycolytic Reserve and Uncoupl
(A) Glycolytic stress test on FIH KO MEFs in 21% oxygen. The area under the cu
polygon represents the response to glucose supplementation after a period of glu
the glycolytic reserve, unmasked upon ATP synthase inhibition.
(B) Glycolytic stress test repeated on FIH KO MEFs under 1% oxygen after 3 da
(C) Glycolytic stress test, on vHL-KO MEFs in 21% oxygen.
(D) Glycolytic stress test on vHL-FIH double-KO MEFs.
(E) Oxidative stress test. The AUC for each genotype was compared with a two-
purple polygon is proportionate to ATP-coupled oxygen consumption. The gree
FCCP addition.
(F) Oxidative stress test. Uncoupled VO2 is in contrast reduced in vHL KO MEF p
(G) Oxidative stress test. vHL/FIH double-KO MEFs resemble vHL KO MEFs in t
(H) Oxidative stress test repeated under 1% oxygen after 3 days of hypoxic cultu
(I) Modified oxidative stress test using a glucose-depleted, palmitate-abundant s
*p < 0.05, **p < 0.01, ****p < 0.0001. OCR and ECAR data are represented as me
every three readings (represented by a single polygon) was computed, and a two
Figure S3.
906 Cell Metabolism 27, 898–913, April 3, 2018natal viability, and so could not be assayed in the same
manner.
We then generated mice with skeletal muscle-specific dele-
tions of FIH, vHL, or both, via employment of an Myf6-pro-
moter-driven cre recombinase transgene (Haldar et al., 2008;
Keller et al., 2004) (Figure S4A). The use of this cre recombinase
was necessary because deletion of vHLwith the striatedmuscle-
specific myosin creatine kinase (CKMM) cre recombinase leads
to mid-gestational lethality in vHL muscle-specific mutants (data
not shown), likely because vHL loss from cardiac muscle (car-
diac deletion occurs to a certain extent in the CKMM cre strain)
has deleterious effects (Lei et al., 2008). Analysis of singular FIH
and vHL mutants showed no specific constitutive shifts in
basal metabolic rate, although FIH skeletal muscle mutants
had a higher nocturnal VO2, when activity of mice is highest,
and vHL mutants tended toward higher VCO2 nocturnally (Fig-
ures S4B–S4E).
During exercise, loss of FIH specifically in skeletal muscle cre-
ates an increase in VO2, analogous to the effects of global FIH
loss (Figure 5D). Loss of skeletal muscle vHL, conversely, causes
a decreased VO2 (Figure 5E), and loss of FIH/vHL causes a sharp
fall-off in VO2 at higher running speeds (Figure 5F). Conversely,
there is a steeper rise in respiratory exchange ratio (RER) with
running speed in vHL and FIH/vHL KO groups, suggesting that
they are more acutely dependent on carbohydrate conversion,
as opposed to fatty acid oxidation, for power output (Figure S4F).
These data draw analogies between metabolic alterations
described above in MEFs and resultant effects on whole-animal
metabolism during exercise in tissue-specific mutants: that loss
of FIH increases oxygen uptake, loss of vHL suppresses it, and
the loss of both causes an accelerated response that dramati-
cally reduces oxidative metabolism.
There are anatomic effects of the loss of both vHL and FIH in
skeletal muscle: while the loss of each singly has no discern-
able effect on fiber type, the loss of both shifts fiber type
identity in superficial quadriceps away from type IIb, or fast
twitch, and toward type I and type IIa, and thus more oxidative
fiber types (Figure 5G). This shift is less marked in skeletal mus-
cle, which is already mainly oxidative, e.g., deep quadriceps
(Figure S4G). Furthermore, vHL loss increases myoglobin
expression in skeletal muscle, regardless of its FIH status
(Figure 5H). Both these changes are in contrast to the role ofed Oxygen Consumption
rve (AUC) for each genotype was compared with a two-tailed t test. The blue
cose starvation, i.e., baseline glycolysis. The green polygon is proportionate to
ys in hypoxic culture.
tailed t test. The blue polygon represents baseline oxygen consumption. The
n polygon is proportionate to uncoupled oxygen consumption, unmasked on
opulations in normoxia.
hat they also have reduced uncoupled VO2 values.
re.
ubstrate medium.
ans ± SEM. n = 3 independent cell culture samples per genotype. The AUC for
-tailed Student’s t test was applied for each pair of AUCs compared. See also
CB
D
E
A
F
G
H
(legend on next page)
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FIH/vHL loss in suppressing oxidative metabolism, and may be
compensatory.
FIH Loss Accelerates Hypoxic Adaptation in Skeletal
Muscle
FIH skeletal muscle deletion mutants have an increased oxygen
debt post-exercise, whereas both vHL and FIH/vHL mutants
have a decreased debt (Figure 6A). This again is correlated
with the increased oxidative metabolism of FIH skeletal muscle
null mutants.
The loss of FIH gives rise to an increase in VO2max relative to the
baseline VO2,whereas this trends toward a decrease in vHL skel-
etalmusclemutant animals and a significant decrease in FIH/vHL
mutants (Figure 6B). In these analyses, loss of FIH is correlated
with FIH mutant mice achieving VO2max at a lower speed than
control mice do, and although this was not seen in vHL mutants,
it was seen in FIH/vHL null mutants (Figure 6C). This may allow
FIH null muscle to conserve glycogen stores at lower exercise in-
tensities, in favor of deploying them at higher exercise intensities,
where anaerobicmetabolismwouldbemoreuseful. Interestingly,
while loss ofmuscle FIH causes a decreased oxygen efficiency at
lower exercise intensities, it does not reduce endurance in a long-
distance running protocol (Figure 6D). This is in contrast with loss
of vHL and FIH/vHL, which both reduce endurance significantly
relative to control littermates.
Two improvements in hypoxic adaptation could serve tomain-
tain exercise performance in the FIH skeletal muscle mutant,
despite the decreased efficiency observed. There is a specific
increase in relative COX activity ratios in FIH mutant muscle
extracts (Figure 6E). Furthermore, Doppler imaging of muscle
perfusion (Figure 6F) revealed that, following exercise to exhaus-
tion, loss of FIH causes an increase in overall perfusion of the
exposed muscle compared with littermate control animals—
part of apotentiated response to themetabolic stress of exercise.
Comparing exercise at moderately low and moderately high
exercise intensities, while the loss of FIH leads to a high VO2 at
11 m/min, this VO2 is more quickly suppressed in mutants as ex-
ercise intensity is increased to 18 m/min (Figure 6G). This sug-
gests that the loss of FIH creates first an increase in VO2 during
exercise, but subsequently acts to suppress oxygen uptake, al-Figure 5. In Vivo Effects of FIH Loss in Mouse Skeletal Muscle Mirror I
(A) Representative immunoblot of FIH in whole organ lysates in a WT mouse, de
(B) Representative immunoblot of molecular oxygen sensors in whole muscle lysa
male WT mice: the predominantly fast twitch extensor digitorum longus (EDL), pre
twitch fibers. Cardiac muscle was sampled separately.
(C) FIH nullizygous mice show increased oxygen consumption (VO2) and carbon
(D) VO2 and VCO2 measured during an incremental uphill exercise protocol in FIH
intensities, suggesting oxygen inefficiency. In contrast, the VCO2 curve was not
curves fitted separately to control and mutant mice measurements.
(E) vHL skeletal muscle mutant mice did not show the qualitative VO2 difference
(F) vHL/FIH muscle double-KO mice show a fall-off in VO2 measurements at low
(G) Fiber type composition in cross-sections of frozen mouse superficial quadrice
deep quadriceps toward slow twitch, more oxidative fiber types. Six frozen sect
(H) The loss of vHL leads to an increase in myoglobin expression in whole-quadrice
no discernible effect.
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; n.s., not significant. Data are rep
with male littermates as controls. n = 7 mice/genotype, unless otherwise stated.
pairwise comparisons (C–F), a two-tailed Student’s t test was used. After curve-fitt
also Figure S4.
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acceleration of metabolic response is also evident in the finding
that mice lacking skeletal muscle FIH have a significantly greater
increase in serum lactate levels following exercise to exhaustion
(Figure 6H). This is correlated with a greater increase in serum
creatine kinase in these mice, indicative of increased anaerobic
stress (Figure S5A). Interestingly, there is a greater shift in the
lipidmetabolome in FIHmutantmuscle than in the overall metab-
olome post-exercise (Figure S5B), suggesting that differential
effects on lipid metabolism likely underlie the metabolic shifts
seen in the mutants, and are potentially facilitating the oxidative
shifts seen.
As eccentric exercise utilizes glycolytic muscles more inten-
sively (Nardone and Schieppati, 1988), we compared the perfor-
mance of FIHmuscle mutant and control mice on downhill tread-
mill running. VO2 in FIH mutants was more blunted than VCO2 in
comparison with controls (Figure 6I). This differed significantly
from that seen in uphill (concentric) running. Consistent with
FIH’s role in accelerating hypoxic adaptation, RER of FIH KO
animals had a steeper relationshipwith running speed in downhill
exercise (Figure S5C) than in the uphill exercise protocol
described above.
Further support for a model wherein FIH loss accelerates
metabolic adaptation was seen from studies in which mice exer-
cised in 12% oxygen. While the loss of FIH increases VO2 under
normoxia, under inhalational hypoxia this is suppressed, with a
decrease in VO2 during exercise (Figure 6K). This result demon-
strates that the loss of FIH accelerates the inhibition of oxidative
metabolism seen in hypoxic muscle tissue. This is analogous to
the suppression of spare respiratory capacity shown in Figure 4,
where FIH null cells exposed to prolonged hypoxia consume
as little oxygen as hypoxic control cells. The mechanism of this
is elusive; given its oxygen sensitivity it likely encompasses
changes in mitochondrial gene expression (Figure S5D), but it
is unrelated to gross mitochondrial structure (Figure S5E).
DISCUSSION
Metabolic shifts in response to changes in energy demand
are complicated by oxygen availability within tissues. HIFts Metabolic Roles in Cells
monstrating different levels of FIH in different tissues.
tes taken from aWTmouse. Various hindlimb muscle samples were taken from
dominantly slow twitch soleus, and quadriceps comprising both fast and slow
dioxide production (VCO2) rates on an incremental uphill treadmill protocol.
skeletal muscle mutant versus control littermate mice over a range of exercise
significantly altered. A two-tailed Student’s t test was applied to equations of
s observed in FIH muscle-specific mutants.
exercise intensities. In contrast, their VCO2 is not altered.
ps from each genotype. Concurrent loss of FIH and vHL shifts fiber identity in
ions were analyzed per mouse.
ps lysates of vHL KOmuscle and vHL/FIH double KO, while the loss of FIH has
resented as means ± SEM. Only male mice were used for in vivo experiments,
For multiple comparisons (A, B, G, and H), a one-way ANOVA was used. For
ing, best-fit equationswere comparedwith an extra sum-of-squares F test. See
AB C D
E
G
J
K
I
F
H
(legend on next page)
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transcription factors modulate this relationship between meta-
bolic response and oxygen partial pressures. There are two
key post-translational mechanisms that regulate HIF activity in
a directly oxygen-dependent manner; we show here that these
pathways act synergistically to modulate metabolism.
Previous studies suggested that FIH impairment upregulates
glycolytic genes (Sakamoto et al., 2011, 2014; Wang et al.,
2014), although not in normoxia (Bracken et al., 2006). In line
with this, we show that cells lacking FIH have a greater capacity
than control cells to increase glycolysis when oxidative meta-
bolism is compromised. We also show that FIH null cells do
not have the same capacity as WT cells for fatty acid oxidation,
indicating that increased glycolysis is likely channeled more
exclusively to pyruvate and not to lactate in these cells as part
of a compensatory metabolic shift. The increase in respiratory
capacity caused by FIH loss is more surprising, given the well-
documented suppression of aerobic metabolism and perfor-
mance with vHL/PHD loss (Fukuda et al., 2007; Kim et al.,
2006). This indicates that FIH plays a fundamentally different
role in regulating metabolic responses than that played by the
PHD/vHL axis of HIF control.
Our cells lacking FIH show no significant increase in glucose
uptake, despite an increase in glycolytic reserve that almost
matches that seen in cells lacking vHL. There is strong evidence
to show that oxidative activity increases when certain steps of
glycolysis are inhibited selectively, e.g., immediately after
hexokinase is inhibited with 2-deoxyglucose (Wu et al., 2006).
Other potential mechanisms for increased oxidative meta-
bolism include shifts in metabolic gene expression. This could
conceivably happen through a threshold-dependent aspect of
HIF-driven gene expression, first toward, and then away from,
oxidative metabolism, or through novel substrates that straddle
metabolic pathways (Cockman et al., 2006; Scholz et al., 2015;
Wilkins et al., 2012; Yang et al., 2013).
Our data indicate that FIH loss accelerates specific metabolic
adaptations to hypoxia.We showed that animals without skeletal
muscle FIH have lower rates of oxidative metabolism when exer-
cising in environmental hypoxia, and when under the glycolytic
stress of downhill running. In these animals, a loss of FIH has
clearly exaggerated a suppression of oxidative metabolism.Figure 6. Effects of FIH Loss on Specific Oxidative Parameters in Male
(A) Oxygen debt in male mice of genotypes indicated, following a running protoco
were compared with an extra sum-of-squares F test.
(B) Normalized VO2,max values in male mice of genotypes indicated, following an
(C) FIH muscle mutant male mice and vHL/FIH double-KO male mice achieve VO
(D) Endurance performance on a distance running protocol.
(E) Cytochrome oxidase (COX) activity in gastrocnemius muscle lysates from ma
(F) Local quadriceps perfusion measured by Doppler imaging before and after an
(G) Changes in VO2 with running intensity within an uphill running protocol.
(H) Relationship between blood lactate levels in resting mice and genotype. Blood
following an incremental uphill treadmill protocol where mice were run to exhaus
(I) Downhill running protocol. Relationships between VO2 and VCO2 measurem
compared with an extra sum-of-squares F test.
(J) Changes in VO2 with running intensity within a downhill running protocol.
(K) Relationship between running speed and VO2 or VCO2, when running under 1
equations of curves fitted separately to control and mutant mice. After curve-fitt
*p < 0.05, **p < 0.01, ***p < 0.001; n.s., not significant. Data are represented as
littermates as controls. n = 7 mice/genotype, unless otherwise stated. For multipl
(A, I, and K), a two-tailed Student’s t test was used. For grouped data (F–H and
910 Cell Metabolism 27, 898–913, April 3, 2018This leads to a unifyingmodel for FIH function: loss of FIH activity
speeds up oxidative processes; this reduces intracellular levels
of oxygen, acting to potentiate PHD inhibition, and thus HIF-1a
accumulation. An accelerated hypoxic metabolic adaptation
then, ultimately, suppresses oxidative metabolism via HIF accu-
mulation. As the FIH enzyme is thought to have a higher oxygen
affinity than the PHD enzymes, ordinarily the loss of PHD activity
and loss of FIH activity should occur sequentially, and in the
wrong order to support this model. However, the differential af-
finities of the PHD enzymes and FIHmight be less relevant where
oxygen levels drop suddenly, a situation in which HIF levels need
to be elevated as rapidly as possible. In such a case, whatever
remaining oxygen there is in the cell would need to be removed
for the cell to remain oxidative as long as possible, and then to as
rapidly as possible accumulate HIF and effect a shift to glycol-
ysis. It could as well be possible that FIH inhibition uses mito-
chondria as oxygen sinks, to propagate the cycle of oxygen
depletion and a subsequent PHD/HIF response spatially, e.g.,
to the muscle cell surface, where some oxygen reserves remain
on myoglobin even under significant hypoxia (Takahashi and
Asano, 2002).
This model would predict that tissues with the greatest need to
retard hypoxic response as long as possible, but then activate it
as rapidly as possible, would also be those that express themost
FIH. As we have shown, skeletal muscle has by far the highest
levels of FIH protein found in the body. Considered alongside
high HIF levels in fast twitch fibers (Pisani and Dechesne, 2005),
and lower HIF levels in slow twitch fibers, successful clamping
of HIF activity could also underlie differential HIF activation in
muscle metabolism. Consistent with this, our group has shown
that FIH expression is significantly higher in athletes undergoing
endurance training (Lindholm and Rundqvist, 2016; Lindholm
et al., 2014). Furtherwork in this areamayshow relevance toother
aspects of human physiology, e.g., certain FIH polymorphisms
being enriched in populations at altitude (Ji et al., 2012). It is
also interesting tonote that theexercise intolerancenoted inChu-
vash polycythemia patients (Formenti et al., 2010) is analogous to
those seen in skeletal muscle vHL deletion mice.
A corollary of our findings and this model would be that, under
conditions of rapid reoxygenation, a rapid suppression of FIHMouse Skeletal Muscle
l of fixed length. n = 5 mice per genotype. After curve-fitting, best-fit equations
incremental uphill running protocol.
2,max at lower exercise intensities compared with controls.
le mice of various genotypes.
uphill running protocol where male mice were run to exhaustion.
lactate levels rose more significantly in FIH muscle-specific mutant male mice,
tion.
ents and downhill running speed. After curve-fitting, best-fit equations were
2% oxygen versus under room air. A two-tailed Student’s t test was applied to
ing, best-fit equations were compared with an extra sum-of-squares F test.
means ± SEM. Only male mice were used for in vivo experiments, with male
e comparisons (B–E), a one-way ANOVA was used. For pairwise comparisons
J), a two-way ANOVA was used. See also Figure S5.
activity could be critical in re-establishing oxidative metabolism
in the presence of accumulated HIF. An acceleration of oxygen
consumption could itself temper the consequences of reoxyge-
nation, e.g., by maintaining a basal, protective level of HIF activ-
ity. Future experiments will address this; one could imagine this
would be key in understanding metabolic adaptations during
ischemia and reperfusion.
Limitations of Study
In this study, we have not delineated catalytic versus non-cata-
lytic actions of FIH; future studies will endeavor to determine
how the hydroxylase acts in an oxygen-dependent manner to
induce the metabolic roles of FIH, and the extent to which, for
example, protein-protein interactions via the JmjC domain are
responsible. In addition, the role of such interaction in seques-
tering FIH may be key in understanding how its hydroxylase ac-
tivity could be restricted within cells.
A key concern here is the overall role of the hydroxylation of
HIF, and thus the direct role played by oxygen. Functions of
FIH outside of its activity as a hydroxylase will need to be fully
explored, as these will illustrate the degree to which it is acting
in an oxygen- and HIF-dependent manner. In the context of hy-
droxylation, there is some disagreement as to the actual oxygen
affinity of the FIH enzyme in in vivo, and, here, defining the spatial
and sub-cellular distribution of FIH will be critical, particularly if
that differs substantially from tissue to tissue. Finally, non-HIF
targets of FIH have been suggested by a number of researchers,
and thus a final definition of the mechanisms of FIH action on
oxidative metabolism will require a detailed inclusion or exclu-
sion of putative FIH targets with a potential metabolic function.
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Rabbit polyclonal anti-alpha tubulin, 1:2000 Cell Signalling Cat#2144; RRID: AB_1968816
Mouse monoclonal anti-beta actin, 1:2000 Sigma Cat#A5316; RRID: AB_476743
Rabbit polyclonal, anti-FIH, 1:1000 Abcam Cat#ab36814; RRID: AB_869843
Rabbit polyclonal, anti-Hsp90, 1:1000 Cell Signalling Cat#4874; RRID: AB_2121214
Rabbit polyclonal, anti-mTOR, 1:1000 Cell Signalling Cat#2983; RRID: AB_2105622
Rabbit polyclonal anti-PGC1a, 1:1000 Santa Cruz Biotechnology Cat#sc-13067; RRID: AB_2166218
Rabbit polyclonal anti-PHD1 1:1000 Bethyl Laboratories Cat#A300-326; RRID: AB_2096867
Rabbit polyclonal anti-PHD2, 1:1000 Novus Biologicals Cat#NB100-2219; RRID: AB_578125
Rabbit polyclonal anti-PHD3, 1:1000 Novus Biologicals Cat#NB100-303; RRID: AB_350220
Mouse monoclonal anti-VHL, 1:500 BD Pharmingen Cat#556347; RRID: AB_396376
Anti-mouse IgG-HRP Donkey, 1:5000 Santa Cruz Biotechnology Cat#sc-2314; RRID: AB_641170
Anti-rabbit IgG-HRP Donkey, 1:5000 R&D Systems/ ThermoScientific Cat#SA1-200; RRID: AB_325994
Goat polyclonal anti-FIH (overexpression experiments), 1:200 Santa Cruz Biotechnology Cat#sc-26219; RRID: AB_2117262
Goat polyclonal anti-FIH (for mitochondrial complex profiling),
1:500
Santa Cruz Biotechnology Cat#sc-26219; RRID: AB_2117262
Mouse monoclonal anti-paxillin (5H11) (overexpression
experiments), 1:1000
Upstate Biotechnology/Millipore Cat#05-417; RRID: AB_309724
Mouse monoclonal anti-lamin B1 (B-10), 1:500 Santa Cruz Biotechnology Cat#sc-374015; RRID: AB_10947408
Bacterial and Virus Strains
Ad-GFP Vector Biolabs Cat#1060
Ad-Cre-GFP Vector Biolabs Cat#1700
Chemicals, Peptides, and Recombinant Proteins
7’-aminoactinomycin D eBioScience Cat#00-6993-50
MitoSOX Thermo Fisher Scientific Cat#M36008
Tetramethylrhodamine methyl ester Thermo Fisher Scientific Cat#T668
RNase A Qiagen Cat#19101
Perchloric acid, 60% Sigma Cat#311413
Potassium phosphate monobasic Fisher Cat#P2853
Potassium phosphate dibasic Fisher Cat#P290500
Tetrabutylammonium-bisulfate Sigma Cat#T7158
HPLC-grade chromatography water Fisher Cat#AC268300025
L-carnitine Roche Cat#11242008001
Sodium palmitate Sigma Cat#P9767
(+)-Etomoxir sodium salt hydrate Sigma Cat#E1905
Seahorse XF modified DMEM media Agilent Technologies Cat#102365-100
Seahorse XF assay calibrant Agilent Technologies Cat#100840-000
Calcein AM dye Life Technologies Cat#C3100MP
Amersham ECL Western Blotting Detection Reagent GE Healthcare Cat#GERPN2124
CelLytic M (previously Cell Lysis M Reagent) Sigma Cat#C2978
Nitro-blue tetrazolium Sigma Cat#11585029001
Critical Commercial Assays
Glucose oxidase assay Merck/Calbiochem, Cat#CBA086
Lactate dehydrogenase assay Cayman Chemical Cat#600450
Citrate synthase activity assay Sigma Cat#CS0720
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Cytochrome c oxidase activity assay BioVision Cat#K287-100
XF Mito Stress Test Kit Agilent Technologies Cat#103015-100
XF Glycolytic Stress Test Kit Agilent Technologies Cat#103020-100
Total OXPHOS Rodent WB Antibody Cocktail Abcam Cat#110413
Deposited Data
Affymetrix microarray data, FIH, VHL and
VHL/FIH null mouse embryonic fibroblasts
Zhang et al. (2010) GEO: GSE20335
Experimental Models: Organisms/Strains
Mouse: VHL fl/fl: C;129S-Vhl<tm1Jae>/J The Jackson Laboratory 004081
Mouse: MCK cre: B6.FVB(129S4)-Tg(Ckmm-cre)5Khn/J The Jackson Laboratory 006475
Mouse: Myf6 cre: B6;129-Myf6<tm2(cre)Mrc>/J The Jackson Laboratory 010528
Mouse: FIH nullizygous Zhang et al. (2010) N/A
Mouse: FIH fl/fl Zhang et al. (2010) N/A
Oligonucleotides
See Table S1 N/A N/A
Recombinant DNA
gBlock double-stranded DNA containing mouse FIH Integrated DNA Technologies N/A
Plasmid: pEF_IRES_puro6 Department of Biochemistry,
University of Adelaide
N/A
Software and Algorithms
NMR Suite 7.6 Chenomx http://www.chenomx.com/
GenePattern Suite The Broad Institute http://software.broadinstitute.org/
Fusion FX System (blot acquisition) Vilber Lourmat https://www.vilber.com/
FlowJo vX (flow cytometry acquisition) FlowJo, LLC https://www.flowjo.com/
XF Hypoxia Rate Calculator Program Agilent Technologies http://www.agilent.com/
FLPI, Laser Speckle Contrast Imager Moor Instruments http://moor.co.uk/
ImageJ NIH https://imagej.nih.gov/ij/
Waters Q-ToF Xevo acquisition software Waters Corporation http://www.waters.com/
Ultra Performance Liquid Chromatogram acquisition software Waters Corporation http://www.waters.com/
Others
SCI-tive Hypoxia Workstation Baker Ruskinn N/A
XF24-3 Analyzer Agilent Technologies N/A
Oxymax indirect calorimetry system with modular treadmill
setup
Columbus Instruments N/ACONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to the Lead Contact, Randall S. Johnson (rsj33@
cam.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Animal work was carried out under UK Home Office guidelines. Mice were housed in a pathogen-free animal facility, provided with
food and water ad libitum, (normal maintenance mouse chow from: SAFE Diets, catalog #A04), and maintained on a 12h light-dark
photoperiod at a regulated 21 degrees C. Mice were genotyped with DNA from ear biopsies, using either in-house PCR or commer-
cial Transnetyx qPCR assays. Mice carrying the FIH gene where exon 2 is flanked by loxP sites (FIHfl/fl) were described previously
(Zhang et al., 2010). Mice possessing loxP sites flanking the VHL promoter and exon 1 (VHLfl/fl) were acquired from The Jackson Lab-
oratory’s repository (JAX 004081). All micewere backcrossed into the C57/BL6J background over at least four generations. Breeding
pairs where both breeders were homozygous for either the floxed FIH (FIHfl/fl) or the floxed VHL allele (VHLfl/fl) were used to generate
FIHfl/fl and VHLfl/fl mice/embryos. FIHfl/fl and VHLfl/fl mice were crossed over three generations to derive FIHfl/flVHLfl/fl mice/embryos.Cell Metabolism 27, 898–913.e1–e7, April 3, 2018 e2
FIHfl/fl or VHLfl/fl mice were crossed with transgenic mice expressing cre recombinase under the control of either the striated mus-
cle-specific creatine kinase CKMM promoter (JAX 006475) or the skeletal muscle-specific Myf6 promoter (JAX 010528), which were
also acquired from The Jackson Laboratory and 010528 respectively). As VHLfl/fl-CKMM cre mice did not survive to birth, VHLfl/fl-
Myf6 cre were likewise generated. Within three generations, skeletal muscle-specific FIH null (FIHfl/fl cre) or VHL null (VHLfl/fl) mice
were derived and used to set up experimental crosses. Only 3 month-old male mice were used in vivo exercise assessments.
Age-matched male littermates (FIHfl/fl, VHLfl/fl) were used as controls. FIHfl/flVHLfl/fl animals were generated in the C57/BL6J back-
ground by crossing FIHfl/fl and VHLfl/fl animals, and subsequently offspring across 2-3 generations carrying both floxed alleles. After
crossing the respective cre recombinase transgenes into the FIHfl/flVHLfl/fl lineage, experimental crosses were set up as follows:
FIHfl/flVHLfl/fl X FIHfl/flVHLfl/fl cre.
FIHD2/+ mice described previously by our group (Zhang et al., 2010) were reconstituted from cryopreserved sperm, and back-
crossed for four generations to the C57/BL6J background. FIHD2/+ heterozygous experimental crosses were used to derive sex-
matched FIH nullizygous (FIHD2/D2) males with male wildtype littermates as controls.
Derivation of Primary Mouse Cells
Primary mouse embryonic fibroblasts (MEFs) were isolated from macerated E12.5-13.5 embryos of the relevant genotypes (whole
litter of embryos used)(mixed cultures were created without selection for gender) and immortalized by stable transfection with
SV40 large T antigen at passage 3. Cells were then subcultured over seventeen more passages. Unless otherwise stated, MEFs
were cultured in a humidified 37C atmosphere of 21% oxygen, 5% carbon dioxide, in high glucose DMEM (Invitrogen) supple-
mented with 10% fetal bovine serum (Gibco), penicillin and streptomycin.
Generation of an FIH Knockout MEF Cell Line Stably Overexpressing Mouse FIH
A gBlock double-stranded DNA containing mouse FIH with 40 bp complementary ends (Integrated DNA Technologies) was cloned
via Gibson assembly into a pEF_IRES_puro6 expression vector. FIH-/- MEFs cultured without penicillin and streptomycin in 100 mm
dishes were transfected at 90% confluency with 30 mg of either a pEF_IRES_FIH_puro6 or an empty vector. Two days after trans-
fection, cells were selected with 2 mg/ml puromycin for two weeks prior to analysis by western blotting and use in Seahorse assays.
METHOD DETAILS
Acute Deletion of Target Genes from MEFs
1x106 immortalized VHLfl/fl FIHfl/fl MEFs were plated briefly, then infected overnight with 100 pfu/cell of adenovirus expressing under
the control of a CMV promoter either eGFP alone (Vector Biolabs), or both eGFP and cre recombinase (Vector Biolabs). After washing
in DPBS, infected cells were trypsinized. The cell population was enriched for eGFP-positive cells using a MoFlo cell sorter
(DakoCytomation). For this study, knockouts were only compared to control cell populations derived from the same parent ‘floxed’
cell population. One passage post-infection, total genomic DNA was purified from a sample of cultured cells using a DNeasy kit
(Qiagen) with RNaseA treatment. Deletion efficiency was quantified with qPCR using TaqMan (Roche) reagents, comparing FIH
and VHL to HIF1a gDNA levels in wildtype and knockout cells. qPCR analysis was performed with an ABI StepOne Plus detection
system.
In Vitro Hypoxic Treatment of MEFs
For hypoxic studies, cells were seeded and cultured in normoxia (21% oxygen) until they were transferred to a temperature-,
humidity- and gas-controlled workstation (Baker Ruskinn) with an atmosphere of 5% CO2 and 1%O2. To permit comparison across
timepoints in a single hypoxic timecourse, all cell samples were cultured for the same total length of time, and transferred into hypoxia
only for the designated timeframe at the end of the protocol. To avoid reoxygenation, RNA, protein, metabolite and media samples
were collected within the hypoxic workstation.
1H-NMR Analysis of Aqueous Metabolites
Aqueous metabolite concentrations were measured in 600ml culture media aliquots. To extract aqueous metabolites from cell
lysates, cell culture media was aspirated and adherent cells washed twice with ice-cold DPBS. Cell layers were immediately scraped
into cold 6% perchloric acid (Sigma), then neutralized completely with 10M KOH. The supernatant was lyophilized and stored until
analysis, where they were reconstituted in 600ml D2O. Metabolite concentrations in both media and cell lysates were eventually
normalized to live cell counts in duplicate wells plated under the same original conditions.
1H-NMR spectroscopywas performed on a 600MHzBruker AvanceNMR spectrometer. Solvent suppression pulse sequencewas
used for acquisition of the 1H-NMR data. DSS was used as an internal standard. Spectral processing consisted zero- and first-order
phase corrections followed by baseline correction using NMR Suite 7.6 (Chenomx). Metabolites were identified by chemical shift
assignments using the same interface. The absolute concentration of metabolites was calculated by normalizing peak area to the
concentration of DSS in each sample calculated by an ERETIC method.e3 Cell Metabolism 27, 898–913.e1–e7, April 3, 2018
Microarray Data Interpretation
An existing Affymetrix microarray dataset relevant to FIH KO, VHL KO and VHL/FIH dKO mouse embryonic fibroblasts was down-
loaded from NCBI GEO (GEO: GDS3769). A principal component analysis was first performed using the relevant function on
GenePattern (Broad Institute, USA) server, to visualize differences. The dataset was filtered through a PreprocessDataset function
on GenePattern, applying lower and upper limits of 0 and 20 000 to Affymetrix results. Genes with minimal variability across
samples (absolute fold change of less than 2 or a range of less than 50) were excluded from analysis. Using GenePattern’s
ComparativeMarkerSelection and ExtractComparativeMarkerResults modules, pairs of genotypes were subject to a two-sided
t-test without permutation.
Taking each knockout / control pair in turn, the fold change and p-value of each gene were plotted against each other using the
MultiPlot module on GenePattern. To extract metabolically relevant information from this dataset, genes with KEGG metabolic
pathway gene ontologies were identified on data plots for clearer visualization.
RNA Extraction from Cells and qRT-PCR Analysis
Total RNA was isolated from cultured cells using an RNeasy kit (Qiagen), with accompanying DNase I treatment (Qiagen). 1mg RNA
was reverse-transcribed using a SuperScript III First Strand Synthesis system (Invitrogen). Resulting cDNA was then diluted 1:20,
and amplified with qPCR using SYBR Green (Roche) reagents in an ABI StepOne Plus detection system. Cycling conditions: Heat
ramp 95C x 10min, extension (95C x 15s, 60C x 1min) x 40 cycles, melt curve 95C x 15s, 60C x 1min, 95C x 15s with 0.3C
increments. Primer sequences are appended (Table S1). Fold change gene expression was calculated by normalisation to 18S,
i.e. 2-DDCT = 2-[(CT,target – CT,housekeeping)hypoxia - (CT,target – CT,housekeeping)normoxia].
Apoptosis Assay
MEFs (150 000) were seeded perwell of a 6well plate. Tomeasure apoptosis, MEFswere exposed to various levels of hypoxia, trypsi-
nized at various timepoints, incubatedwith 7’-AAD (1:20) (eBioScience) in DPBS at 4C for 15min, then analyzed for the percentage of
dead (positively-stained) cells using flow cytometry.
Enzyme-Based Metabolic Assays
MEFs (150 000) were cultured for up to 72h in 21% or 1% oxygen. A media sample was taken at different timepoints for colorimetric
quantification of glucose concentration by a glucose oxidase assay (Merck/Calbiochem), and lactate concentration by a lactate de-
hydrogenase assay (Cayman Chemical), according to manufacturers’ instructions. Glucose and lactate measurements from uncon-
ditionedmedia were used for comparison. Adherent MEFs were washed and lysed in a non-denaturing Cell M Lysis Reagent (Sigma)
containing proteinase inhibitor. Lysates were centrifuged, and the supernatant kept at -80C until analysis. Native citrate synthase
activity (Sigma) and cytochrome c oxidase activity (BioVision) in lysates was measured using colorimetric kinetic measurements ac-
cording to manufacturers’ instructions, using a Tecan Sunrise microplate-reader. In particular, COX activity was measured by
following the oxidation of reduced cytochrome c as an absorbance decrease at 550nm. All readings were then normalized to viable
cell counts obtained from duplicate wells plated under the original conditions.
Flow Cytometric Analysis
To characterize various mitochondrial parameters in MEF populations, MEFs were cultured for 48h, then trypsinized and stained with
one of the following at 4C over 20min in DPBS: 10mMMitoSOX (Thermo Fisher), 200nM tetramethylrhodamine methyl ester (Thermo
Fisher). Stained cells were then washed and kept in cold DPBS briefly before analysis. Results were acquired with a Fortessa
(Becton-Dickinson) flow cytometer, and analyzed in FlowJo vX.
Quantification of mtDNA
Total genomic DNA was extracted from cultured cells using a DNeasy kit (Qiagen) with RNaseA treatment. To approximate mtDNA
content (Huo andScarpulla, 2001; Shen et al., 2004), the relative quantities ofmtDNA genes encoding cytochromeB andmCO-1, and
rDNA genes encoding 18S and m5S, were determined by qPCR. A list of primer sequences is appended (Table S1).
HPLC Assay for High Energy Nucleotides
Cell culture media was removed and cells were washed twice with ice-cold DPBS. Cell layers were scraped into ice-cold 6%
perchloric acid. A known amount of cytidine monophosphate (Sigma) was added as an internal standard at the same time. Cells
were then immediately scraped and collected. Samples were incubated on ice for 10min, then centrifuged. Universal indicator
solution (Fisher) was added to supernatants. The samples were neutralized with KOH and the supernatants were collected and
lyophilized.
For analysis, each sample was reconstituted in 200-300ml of HPLC-grade water (Fisher), then 20ml was injected onto a 3.0 mm
SUPELCOSIL LC-18-T HPLC column (Sigma) using a Dionex Ultimate 3000 system. The column temperature was held at 30C
and the flow rate was 1.0 ml/min. Buffer A consisted of 100mM KH2PO4/K2HPO4 (Fisher) with 4mM tetrabutylammonium-bisulfate
(Sigma) in water. Buffer B consisted of 100mM KH2PO4/K2HPO4 with 4mM tetrabutylammonium-bisulfate in 30% methanol (Fisher
Scientific). After 2.5min at 0%buffer B, the gradient profile startedwith a linear increase of buffer B to 30%until 5.0min, followed by a
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20.0min, the gradient was reversed to 0%buffer B and held for 5.0 min. Detection was achieved bymeasuring absorbance at 254nm
and quantified against the absorbance of known standards.
Seahorse XF Glycolytic and Oxidative Stress Tests
An XF24-3 Analyzer (Agilent) equipped with fluorescent biosensors was used to measure local pH or pO2 changes in culture media.
Briefly, 50 000 MEFs were seeded per culture well overnight (8-12h), then washed and equilibrated in glucose/pyruvate-free, unbuf-
fered (glycolysis stress test) or low glucose/low pyruvate, HEPES-free DMEM for 1h at 37C, in a CO2-free atmosphere. After taking
baseline recordings, reagents were injected successively into eachwell, with pH and pO2 tracked in real-time (2min-1min-2min / mix-
wait-measure cycles, with three cycles per injection). Working concentrations optimized for the ‘‘glycolytic stress test’’ were 10mM
glucose, 2.5mM oligomycin and 12mM 2-deoxyglucose. Those used for the ‘‘mitochondrial stress test" were 10mM glucose, 0.8mM
oligomycin, 1.2mM FCCP and a 4mM antimycin/2mM rotenone mixture. After the final reading, live cells were stained with calcein AM
dye (Life Technologies), and each well imaged for particle analysis in ImageJ. Extracellular acidification rates and oxygen consump-
tion rates for each well were divided by the live cell counts for the same well, and the final result normalized to ‘‘50 000 viable cells at
the end of the experiment’’.
To measure fatty acid oxidation, cells were first starved over 24h in glucose/pyruvate-limited DMEM supplemented with 0.5mM
carnitine. Thereafter, cells were washed and kept briefly in Krebs-Henseleit Buffer. Either BSA-conjugated palmitate or BSA vehicle
was added to wells, and the oxidative stress test was immediately run. Fatty acid oxidation was taken to be the difference between
palmitate and vehicle-treated readouts. Separate control wells treated with 40mM etomoxir 15min before the experiment were found
to be unresponsive to palmitate – confirming that oxidation measured in this setup was indeed attributable to fatty acids.
To acquire similar readouts under hypoxic conditions, the XF24-3 Analyzer (Agilent) was subsequently placed within a gas flow-
controlled Perspex hermetic chamber. The chamber was not humidity- or temperature-controlled, but a fan promoted internal air
circulation. The chamber was maintained at 1% oxygen, 0% carbon dioxide. The assay was optimized and cells were seeded at
a density that allowed anoxia to be avoided during each measurement cycle. The instrument and biosensors were allowed to equil-
ibrate in this hypoxic atmosphere overnight, while aliquots of assay reagents were thawed and equilibrated 1h in advance.
MEFs (20 000) were seeded per well, and cultured for 24h at 1% oxygen, 5% carbon dioxide. After cells were washed and left in XF
media, they were transferred into the Analyzer via an airtight container, and were left to equilibrate with the instrument’s carbon
dioxide-free atmosphere for 1h. The glycolytic and mitochondrial stress tests were performed as previously described. Reagent
working concentrations were modified as follows: For the ‘‘glycolytic stress test’’, 10mM glucose, 2.5mM oligomycin and 12mM
2-deoxyglucose. For the ‘‘mitochondrial stress test", 10mM glucose, 0.6mM oligomycin, 1mM FCCP and a 2mM antimycin/1mM
rotenone mixture.
To analyze data acquired under hypoxia, extracellular acidification rates did not require further correction. Oxygen consumption
rates were corrected using the XF Hypoxia Rate Calculator Program (Seahorse Bioscience), which was calibrated by wells where
anoxia was ‘induced’ by repeated injections of 100mMNa2SO3 into XF assay calibrant.Well readingswere finally normalized to viable
cell counts performed at the end of each experiment, taken to be the number of cells stained positively by calcein AM dye (Life
Technologies).
Western Blotting of Cells and Organ Lysates
Confluent layers of cultured cells were washed once with DPBS and scraped into ice-cold RIPA buffer (1% PMSF, 2% proteinase
inhibitor) for protein extraction. Primary tissues were homogenized under liquid nitrogen with mortar and pestle, then protein was
likewise extracted with a 1:1 tissue:RIPA volume ratio. Lysates (15mg) were separated on either 3-8% Tris-Acetate or 4-12% Bis-
Tris gels (Invitrogen) in SDS buffer, then transferred onto nitrocellulose membranes with a TransBlot system (BioRad). Immunoblot-
ting was performed by standard methods. A list of primary and secondary antibodies is appended in the Key Resources Table. Blots
were developed with an Amersham ECLWestern Blotting Detection Reagent (GE Healthcare) and visualized with a Fusion FX system
(Vilber Lourmat). Densitometric analysis was performed with ImageJ.
Comparison of Expression of Mitochondrial Electron Transfer Chain Complexes in WT and FIH KO
MEFs seeded in six-well plates were lysed in 100uL/well RIPA buffer. Lysates were separated on 4-12% SDS Page, transferred to
nitrocellulose membrane. Immunoblotting was performed with a Total OXPHOS Rodent WB Antibody Cocktail (Abcam 110413)
1:250, using rat heart mitochondria as a positive control.
Tail Vein Blood Sampling
Serum obtained from tail vein blood samples was analysed by a biochemical core facility using the following assays (Dade-Behring):
creatine kinase by Oliver and Rosalki method; glucose by hexose-6-phosphate dehydrogenase assay; high density lipoprotein by
homogenous detergent solubility / enzyme assay; lactate by Marbech and Weil method.
Indirect Calorimetry
Mouse energy expenditure was measured with an Oxymax system (Columbus Instruments). Each mouse was placed in a metabolic
chamber with a controlled supply of room air and monitored over a period of 24h, during which it was provided freely with food and
water. Each pair of wildtype and knockout littermates was analyzed during the same 24h timeframe. O2 and CO2% at each chambere5 Cell Metabolism 27, 898–913.e1–e7, April 3, 2018
inlet and outlet were monitored with a paramagnetic O2 sensor and CO2 sensor and analyzed to obtain weight-normalized metabolic
parameters (VO2, VCO2 and respiratory exchange ratios) over time.
Incremental Uphill and Downhill Treadmill Protocols
All calorimetry and treadmill studieswere carried out at a controlled 21 degree C ambient environmental temperature. No exclusion or
inclusion criteria were employed when selecting mice in these studies.
Untrained knockout and control mouse littermates were run on an enclosed-chamber modular treadmill (Columbus Instruments) at
a 5 incline, beginning at 5m/min, with an acceleration of 1m/min2 until the animal was exhausted, exhaustion being defined as the
point where mice refused to run even when coming into contact with a low-voltage power grid. Oxygen and carbon dioxide into and
out of the treadmill chamber was monitored using a carbon dioxide and paramagnetic oxygen sensor within an Oxymax system.
VO2,max was defined as the maximum VO2 achieved during this assessment, while the baseline VO2 was taken to be that at rest,
just before the treadmill was started at 5m/min. Power was calculated as the product of bodyweight in kg, acceleration due to gravity,
and vertical speed (horizontal speed 3 angle of incline). To assess downhill running, the VO2,max protocol was repeated, with the
treadmill positioned at a 10 decline instead.
To assess the impact of inhalational hypoxia on running performance, mice were first allowed to acclimatize for 5h in hermetic
chambers supplied at 12% oxygen. They were then transferred to the modular treadmill setup (Columbus Instruments) with a joint
gas supply, and the VO2,max protocol was repeated.
To assess endurance, with at least 72h rest between any two protocols, mice were run at 70% of their pre-determined, maximum
achievable speed at a 5 incline. Distance run to exhaustion was noted. To measure oxygen debt, from a resting state, mice were
immediately stepped up to 70% of their pre-determined, maximum achievable speed at a 5 incline, run for 15min, then immediately
stepped down to rest. The resulting plot of VO2 over time was used for analysis. Oxygen debt was defined as the area under the VO2
curve following the ‘step-down’.
Doppler Imaging
Procedures were carried out at a 21 degree C environmental temperature. Mice were anaesthetized with isoflurane atop a warm plat-
form, and the hindlimb was exposed by a skin flap. Doppler imaging was performed with a laser speckle contrast imager (FLPI, Moor
Instruments). The charged coupled device camera was positioned 20cm above the exposed femoral artery and its branches. Four
sequential images were acquired in a in a long exposure, high resolution setting (camera exposure 1min), integrated to produce a
scaled flux image of local blood flow velocity. Perfusion was reported in arbitrary units. Three regions of interest across the femoral
artery were analyzed and the data pooled. Imaging and analysis was done in a blinded fashion. Mice were culled at the end of the
procedure by cervical dislocation.
Tissue Harvest
At the end of the experimental period, mice were culled by cervical dislocation. Samples of gastrocnemius, quadriceps and soleus
were immediately snap-frozen in liquid nitrogen, while some samples were prepared for histology as described below.
Native Enzyme Activity Assays
Tissuewas homogenized under liquid nitrogen using amortar and pestle setup. Tissue homogenates were lysed in approximately 1:1
(v/v) non-denaturing Cell M Lysis Reagent (Sigma) containing proteinase inhibitor. Lysates were centrifuged, and supernatants kept
at -80C until analysis. Native citrate synthase activity (Sigma, CS0720) and cytochrome c oxidase activity (BioVision, K287-100) in
lysates was measured using colorimetric kinetic measurements using a Tecan microplate reader.
Preparation of Tissue for Histology
For muscle histology, samples of quadriceps were harvested from untrained mice of all genotypes and flash-frozen in OCT (Tissue-
Tek) by immersing in a dewar of liquid nitrogen-cooled isopentane. Tissue sections (10mm) were cut with a cryostat for histological
analysis.
Fiber Type Differentiation Using NADH-tetrazolium Reductase Method
Frozen, unfixedmouse quadriceps sections were incubated for 30min in 0.16%NADH in 0.05M Tris buffer (pH7.6) containing freshly-
added 0.1% nitro-blue tetrazolium (Sigma), at 37C. Sections were washed with three exchanges of deionised water. Unbound nitro-
blue tetrazolium was removed using acetone solutions in the following sequence: 30%, 60%, 90%, 60%, 30%. Finally, slides were
rinsed several times with deionized water and cover-slipped with an aqueous mounting medium. Purple formazan is deposited at
sites of mitochondria; more oxidative fibers appear darker, as do blood vessels. The segmentation function of the MRI Adipocyte
Tools toolset in ImageJ was used to demarcate and enumerate individual myofibers of a minimum surface area per field. The staining
intensities of individual fibers were then stratified into three grades using a LUT editor, and the fibers belonging to each grade were
then manually counted by two blinded observers, finally expressed as a ratio of total myofibers per field.Cell Metabolism 27, 898–913.e1–e7, April 3, 2018 e6
Metabolite Extraction from Muscle Samples
Gastrocnemius samples of known mass were homogenized under liquid nitrogen using a mortar and pestle setup. 100ul of each ho-
mogenate was added to 300ml of ice-coldmethanol:chloroform (2:1) and vortexed. Mixtures were kept on ice for 15min, then 100ul of
chloroform and 100ml of water were added to each tube. Samples were centrifuged for 7min at 13 300rpm, then the lower (lipophilic)
fraction was carefully separated and dried in a fume hood overnight, then stored at -80C until analysis.
LC-MS Analysis of Lipid Species
75% of dried lipophilic fractions were used for liquid chromatography-mass spectrometry (LC-MS) analysis of intact lipids. Each
extract was reconstituted in 300 ml isopropanol-acetonitrile-water (2:1:1 v/v), and then 100 ml of this was diluted in 1.4ml IPA-aceto-
nitrile-water. Samples were then analysed using a Waters Q-ToF Xevo (Waters Corporation, Manchester) combined with an Acquity
Ultra Performance Liquid Chromatogram (UPLC). 4 ml of the sample was injected onto an Acquity UPLCCharged Surface Hybrid C18
column (1.7 mm x 2.1 mm x 100 mm) (Waters Corporation, Manchester, UK) held at 55C. The binary solvent system (flow rate
0.400 ml/min) consisted of solvent A containing HPLC grade acetonitrile-water (60:40) with 10 mM ammonium formate and solvent
B consisting of LC-MS grade acetonitrile-isopropanol (10:90) and 10mM ammonium formate. The gradient started from 60%A/40%
B, reached 99% B in 18 min, then returned back to the starting condition, and remained there for the next 2 min. The data was
collected over the mass range ofm/z 105-1800 with a scan duration of 0.2s. The source temperature was set at 120C and nitrogen
was used as the desolvation gas (900 L/h). The voltages of the sampling cone, extraction cone and capillary were 30 kV, 3.5 kV and 2
kV respectively, with a collision energy of 6 V for each single scan, and a collision ramp from 20 to 40 V for the fragmentation function.
As lockmass, a solution of 2 ng/ml acetonitrile-water (50:50) leucine enkephaline (m/z 556.2771) with 0.1% formic acid was infused
into the instrument every 30 seconds.
QUANTIFICATION AND STATISTICAL ANALYSIS
Analyses were performed with GraphPad Prism 7. Data are presented as mean ± SD. All experiments were conducted at least three
times with representative data shown, and where appropriate, examined for normal distribution by histogram. Statistically significant
differences were determined using the Student’s t test. Correlations were evaluated using the Pearson r method. A value of p <0.05
was considered statistically significant. For the analyses of metabolites, comparisons between groups were made using multiple
t tests with a false discovery rate of 0.05. For comparison among multiple groups a, one-way ANOVA was used; for comparison
of grouped data, a two-way ANOVA was used. Statistical parameters can be found in the figure legends.e7 Cell Metabolism 27, 898–913.e1–e7, April 3, 2018
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Supplemental	Figure	Legends	
Figure	S1	 Genetic	 deletion	 of	 FIH	 and/or	 VHL	 using	 a	 cre-lox	 system.	 Related	 to	
Figure	1.	
A. Immunoblots	of	whole	cell	lysates.		
	
Figure	S2	 Further	metabolic	characterization	of	FIH	and/or	VHL	null	cells.	Related	to	
Figure	2.	
A. Culture	 media	 lactate	 levels.	 Mouse	 embryonic	 fibroblast	 (MEF)	 genotypes	 as	
specified.		
B. Culture	media	glucose	levels.	MEF	genotypes	as	specified.		
C. Flow	 cytometry;	 representative	 histograms	 of	 cell	 count	 versus	 MitoSOX	
(superoxide	 stain)	 fluorescence,	 with	 shaded	 graph	 representing	 unstained	
controls.	Three	experiments	were	performed	with	two	biological	replicates	each;	
the	histogram	provided	is	representative	of	one	of	these	experiments.		
D. Flow	cytometry;	MitoSOX	fluorescence	as	before,	but	of	cells	after	two	days	of	
culture	in	a	hypoxic	chamber.	
E. Flow	 cytometry;	 representative	 histograms	 of	 cell	 count	 versus	 TMRM	
fluorescence	 (indicator	 of	 mitochondrial	 membrane	 potential),	 with	 shaded	
graph	representing	unstained	controls.		
F. Flow	 cytometry;	 TMRM	 fluorescence	 as	 before,	 but	 of	 cells	 after	 two	 days	 of	
culture	in	a	hypoxic	chamber.	
	
Figure	S3	 Rescue	of	oxidative	phenotype	 in	FIH	null	cells	with	FIH	overexpression.	
Related	to	Figure	4.	
A. Immunoblot	 of	 whole	 cell	 extracts	 from	 FIH-/-	 MEF	 parental	 cell	 line	 stably	
transfected	with	empty	vector	(CTRL),	FIH	parental	cell	line	stably	overexpressing	
FIH	(OE	FIH),	parental	FIH-/-	line	and	the	FIH	fl/fl	line	probed	for	FIH	and	α-Paxillin.	
Black	line	indicates	non-adjacent	lanes	on	the	same	immunoblot.	
B. Oxidative	 stress	 test	 performed	 on	 the	 FIH-/-	 MEF	 parental	 cell	 line	 stably	
transfected	 with	 empty	 vector	 (CTRL)	 and	 the	 FIH	 parental	 cell	 line	 stably	
overexpressing	FIH	(OE	FIH),	using	a	Seahorse	XFe96	Analyzer.	Cells	were	seeded	
in	 an	XF96	 cell	 culture	microplate	 at	 10,000	 cells	 per	well	 overnight,	 and	 then	
washed,	equilibrated	and	assayed	 in	XF	base	media	with	10	mM	glucose	and	1	
mM	pyruvate.	The	assay	was	performed	using	0.8	µM	oligomycin,	1.2	µM	FCCP,	
and	a	mixture	of	2	µM	rotenone	and	2	µM	antimycin	A.	Cells	were	stained	with	
NucBlue	 Live	 ReadyProbes	 reagent	 (Thermo	 Fisher	 Scientific)	 and	 each	 well	
imaged	for	particle	analysis	in	ImageJ.	OCR	data	are	presented	as	mean	±	SEM.	n	
=	6	independent	cell	culture	samples	per	genotype.	
	
Figure	S4	 Further	metabolic	characterization	of	FIH	and/or	VHL	null	skeletal	muscle	
mutant	mice.	Related	to	Figure	5.	
A. Immunoblots	of	whole	muscle	lysates	showing	successful,	global	deletion	of	FIH	
in	 FIH	 nullizygous	 mice,	 striated	 muscle-specific	 deletion	 of	 FIH	 using	 muscle	
creatine	kinase	(CKMM)-cre,	and	skeletal	muscle-specific	deletion	of	VHL	and/or	
FIH	using	Myf6-cre.		
B. 24h	 indirect	 calorimetry	 readouts	 showing	baseline	VO2	values	of	unrestrained	
mice,	with	dark	(shaded	in	grey)	and	light	(unshaded)	photoperiods	demarcated.		
C. 24h	indirect	calorimetry	readouts	showing	baseline	VCO2	values	of	unrestrained	
mice,	with	dark	(shaded	in	grey)	and	light	(unshaded)	photoperiods	demarcated.	
D. VHL	 muscle-specific	 mutant	 mice.	 24h	 indirect	 calorimetry	 readouts	 (baseline	
VO2	values)	in	dark	and	light	photoperiods.	
E. VHL	 muscle-specific	 mutant	 mice.	 24h	 indirect	 calorimetry	 readouts	 (baseline	
VCO2	values)	in	dark	and	light	photoperiods.	
F. Relationship	between	respiratory	exchange	ratio	(RER)	and	uphill	running	speed,	
graphed	 for	 muscle-specific	 mutant	 mice	 of	 various	 genotypes	 and	 their	
respective	control	mice.	For	statistical	analysis,	a	linear	fit	was	assumed,	and	the	
best-fit	equations	were	compared.	n=7	per	group.		
G. Fiber	type	composition	in	cross-sections	of	deep	quadriceps,	based	on	fiber	type-
specific	staining.	Loss	of	VHL/FIH	decreases	the	percentage	of	type	IIb	glycolytic	
fibers.	
	
Figure	S5	 Further	metabolic	characterization	of	FIH-null	skeletal	muscle.	Related	to	
Figure	6.	
A. Running	 uphill	 to	 exhaustion	 increases	 circulating	 blood	 creatine	 kinase	 in	 the	
FIH	muscle-specific	mutant,	while	blunting	the	high	circulating	HDL	levels	seen	in	
knockout	mice	at	rest.	Blood	glucose	is	not	affected.		
B. Principal	 component	 analysis	 comparing	 the	 lipophilic	 metabolomes	 of	
gastrocnemius	 samples	 from	 FIH	 muscle-specific	 mutant	 and	 control	 mice,	 at	
rest	and	after	running	uphill	to	exhaustion	(“postex”).	A	list	of	metabolites	best	
distinguishing	 the	 genotypes	 was	 determined	 for	 each	 condition	 (rest	 versus	
exercise),	 and	 filtered	 by	 p<0.05	 (resulting	 in	 35	 metabolites	 at	 rest,	 and	 50	
metabolites	 post-exercise),	 then	 parsed	 into	 lipid	 metabolite	 classes	 by	 their	
retention	 times.	 The	 composition	 of	 each	 series	 of	 "top	 hits"	 has	 been	
schematized	and	presented	here.		
C. FIH	muscle-specific	mutants’	RERs	showed	greater	separation	from	control	RERs	
(p=0.0005)	at	high	speeds	of	downhill	running.	For	statistical	analysis,	a	linear	fit	
was	assumed,	and	the	best-fit	equations	were	compared.	n=7	per	group.			
D. Oxidative	gene	mRNA	profiling	from	whole	muscle	lysates.	n=5	mice	per	group.	
E. Representative	 transmission	electron	microscopy	 images	of	 FIH	muscle-specific	
mutant	 soleus	 and	 gastrocnemius	 samples	 showing	 no	 gross	 distortions	 in	
mitochondrial	structure	and	distribution.	Scale	bar	representative	of	2	microns.	
	
*	p<0.05,	 **	p<0.01,	 ***	p<0.001.	Data	are	 represented	as	mean	±	 SEM.	 For	multiple	
comparisons,	 a	 one-way	 ANOVA	 was	 used.	 For	 pairwise	 comparisons,	 a	 two-tailed	
student’s	t-test	was	used.	For	in	vitro	experiments,	n=3	independent	cell	culture	samples	
per	group.	For	in	vivo	experiments,	only	male	mice	were	used,	with	male	littermates	as	
controls.	n=7	mice/genotype.	
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Table	S1		 qPCR	primers.	Related	to	Methods.		
12S	(mtDNA)	rRNA	forward	 ACCGCGGTCATACGATTAAC			
12S	(mtDNA)	rRNA	reverse	 CCCAGTTTGGGTCTTAGCTG		
18S	rRNA	forward	 CGGCGACGACCCATTCGAAC		
18S	rRNA	reverse	 GAATCGAACCCTGATTCCC			
18S	rDNA	forward	 TAGAGGGACAAGTGGCGTTC	
18S	rDNA	reverse	 CGCTGAGCCAGTCAGTGT	
Ca9	forward	 CCTCTCCCGGAACTGAGCCTAT			
Ca9	reverse	 TGTTCTGAGCCTGGGTGATCTG		
catalase	forward	 AGCGACCAGATGAAGCAGTG	
catalase	reverse	 TCCGCTCTCTGTCAAAGTGTG	
Cox4i1	forward	 ATTGGCAAGAGAGCCATTTCTAC		
Cox4i1	reverse	 CACGCCGATCAGCGTAAGT		
Cox4i2	forward	 CTGCCCGGAGTCTGGTAATG		
Cox4i2	reverse	 CAGTCAACGTAGGGGGTCATC		
Cox7a1	forward	 GCTCTGGTCCGGTCTTTTAGC		
Cox7a1	reverse	 GTACTGGGAGGTCATTGTCGG		
Cox7a2	forward	 ATCAGCACCACTTCACGAAGG	
Cox7a2	reverse	 GAACTGGCATCCCATTATCCTC	
Cyt	b	forward	 GCTTTCCACTTCATCTTACCATTTA		
Cyt	b	reverse	 TGTTGGGTTGTTTGATCCTG		
Cyt	c	forward	 CCAAATCTCCACGGTCTGTTC		
Cyt	c	reverse	 ATCAGGGTATCCTCTCCCCAG		
Eno1	forward	 TGCGTCCACTGGCATCTAC		
Eno1reverse	 CAGAGCAGGCGCAATAGTTTTA		
Fih	forward	 GTGCCAGCACCCATAAGTT				
Fih	reverse	 CGCGCTGCTGTATAGCTT		
Gapdh	forward	 ACCACAGTCCATGCCATCAC		
Gapdh	reverse	 TCCACCACCCTGTTGCTGTA		
Glut1	forward	 GGGCATGTGCTTCCAGTATGT		
Glut1reverse	 ACGAGGAGCACCGTGAAGAT			
Gpi	forward	 TCAAGCTGCGCGAACTTTTTG		
Gpi	reverse	 GGTTCTTGGAGTAGTCCACCAG		
HkII	forward	 TGATCGCCTGCTTATTCACGG		
HkII	reverse	 AACCGCCTAGAAATCTCCAGA		
Ldha	forward	 TGTCTCCAGCAAAGACTACTGT		
Ldha	reverse	 GACTGTACTTGACAATGTTGGGA			
Lonp1	forward	 CGGGAAGATCATCCAGTGTT		
Lonp1	reverse	 ACGTCCAGGTAGTGGTCCAG		
M5s_rDNA	forward	 ACCGTCTAGCCGTCCTCCTT	
M5s_rDNA	reverse	 CCCACTGAGGATGGATACATG	
Mcd	fwd	 GCACGTCCGGGAAATGAAC	
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Mcd	rev	 GCCTCACACTCGCTGATCTT	
Mco1	forward	 CCCAGATATAGCATTCCCACGA	
Mco1	reverse	 AGCAAGCTCGTGTGTCTACATC	
Mct1	forward	 TGTTAGTCGGAGCCTTCATTTC		
Mct1	reverse	 CACTGGTCGTTGCACTGAATA		
Mct4	forward	 TCACGGGTTTCTCCTACGC		
Mct4	reverse	 GCCAAAGCGGTTCACACAC		
Mxi1	forward	 GATTCAGAGCGAGAGGAGATTG		
Mxi1reverse	 ACACTGGCACTGGAGTAACC		
Pdk1	forward	 GAAGCAGTTCCTGGACTTCG		
Pdk1	reverse	 CCAACTTTGCACCAGCTGTA		
Pgc1α	forward	 TATGGAGTGACATAGAGTGTGCT		
Pgc1α	reverse	 CCACTTCAATCCACCCAGAAAG		
Pgk	forward	 CTGTGGTACTGAGAGCAGCAAGA			
Pgk	reverse	 CAGGACCATTCCAAACAATCTG		
Pkm	forward	 GCCGCCTGGACATTGACTC		
Pkm	reverse	 CCATGAGAGAAATTCAGCCGAG		
Sod1	forward	 AACCAGTTGTGTTGTCAGGAC	
Sod1	reverse	 CCACCATGTTTCTTAGAGTGAGG	
Sod2	forward	 CAGACCTGCCTTACGACTATGG	
Sod2	reverse	 CTCGGTGGCGTTGAGATTGTT	
Tpi	forward	 CCAGGAAGTTCTTCGTTGGGG		
Tpi	reverse	 CAAAGTCGATGTAAGCGGTGG		
	
Table	S2	 Extracellular	metabolites	distinguishing	FIH	KO	over	control	MEF	media,	
from	1H-NMR	analysis.	Related	to	Figure	1.	A	positive	t.stat	means	that	a	
particular	metabolite	is	upregulated	in	FIH	KO	compared	to	control	MEFs,	
whereas	a	negative	t.stat	means	it	is	downregulated.	
		 t.stat	 p	value	 FDR	
Alanine	 18.962	 5.71E-21	 1.31E-19	
Formate	 12.42	 5.98E-15	 6.88E-14	
Glutamine	 -10.17	 2.14E-12	 1.64E-11	
Lactate	 6.1856	 3.17E-07	 1.82E-06	
Glucose	 -5.9558	 6.55E-07	 3.01E-06	
Pyruvate	 4.7558	 2.84E-05	 0.00010881	
Choline	 -4.5858	 4.80E-05	 0.00015583	
Isoleucine	 -4.5461	 5.42E-05	 0.00015583	
Leucine	 -3.9729	 0.00030602	 0.00078204	
Pyroglutamate	 -2.4035	 0.021227	 0.048823		
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Table	S3	 Extracellular	metabolites	distinguishing	VHL	KO	over	control	MEF	media,	
1H-NMR	analysis.	Related	to	Figure	1.	A	positive	t.stat	means	that	a	particular	
metabolite	is	upregulated	in	VHL	KO	compared	to	control	MEFs,	whereas	a	
negative	t.stat	means	it	is	downregulated.	
		 t.stat	 p	value	 FDR	
Lactate	 19.199	 1.80E-12	 2.98E-11	
Formate	 18.744	 2.60E-12	 2.98E-11	
Pyruvate	 -11.247	 5.23E-09	 4.01E-08	
Glutamine	 8.3394	 3.22E-07	 1.85E-06	
Alanine	 7.1587	 2.27E-06	 1.05E-05	
Glycine	 5.5381	 4.50E-05	 0.00017242	
Leucine	 5.0049	 0.00012959	 0.00037663	
Choline	 4.9995	 0.000131	 0.00037663	
Glucose	 4.822	 0.00018773	 0.00047974	
Acetate	 -4.6787	 0.00025158	 0.00057864	
Methionine	 3.1095	 0.0067443	 0.014102	
Threonine	 -2.7998	 0.012846	 0.024622	
Isoleucine	 2.7013	 0.01573	 0.02783	
Arginine	 2.6512	 0.017426	 0.028629			
